Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03663283 · ClinicalTrials.gov registry record · Phase 4
Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 104
- Enrollment target
NCT03663283: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT03663283 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03663283, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 104 participants
- Enrollment target
Study Summary
The objective of this study is to determine if peripheral nerve block with liposomal bupivacaine in combination with standard bupivacaine will prolong the duration of block, improve pain scores, and decrease opioid utilization in the post-operative period when compared to peripheral nerve block with standard bupivacaine alone.
Interventions
- DRUG Liposomal Bupivacaine
- DRUG Bupivacaine Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2018-10-29 |
| Est. Completion | 2020-02-14 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03663283
The ClinicalTrials.gov registry entry for NCT03663283 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Liposomal Bupivacaine is the first listed.
NCT03663283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03663283 about?
NCT03663283 is a clinical study titled "Liposomal Bupivacaine Interscalene Nerve Block in Shoulder Arthroplasty". The objective of this study is to determine if peripheral nerve block with liposomal bupivacaine in combination with standard bupivacaine will prolong the duration of block, improve pain scores, and decrease opioid utilization in the post-operative period when compared to peripheral nerve block with...
What is the current status of trial NCT03663283?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 104 participants. The study started on 2018-10-29. Estimated completion is 2020-02-14.
What interventions are being tested in trial NCT03663283?
The interventions under investigation include: Liposomal Bupivacaine (DRUG), Bupivacaine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT03663283?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.